Invitation to Submit an Abstract
We encourage you to submit an abstract on work focusing on any aspect of the measurement of acute pain in animals, or the use of animals as naturally occurring disease models in translational acute pain research. Abstracts are due on July 15th, 2019 at 11pm CST.
PLEASE READ BEFORE PREPARING AND SUBMITTING ABSTRACTS
Two abstracts are required (a short abstract for publication on the PAWS website and a long abstract for scientific review). Email both the completed short and long abstracts to: email@example.com. You should receive an email message within 48 hours of submission, confirming that submission materials were received, readable, and correctly formatted.
SHORT abstract: This abstract will be used for publication on the PAWS website and the Conference Proceedings and is limited to 250 words in Arial 12 pt formatting. This is the published abstract, so please ensure care with your language and grammar - despite the word limit.
LONG abstract: The abstract length is limited to 800 words (excluding references, tables and figures). Single space between paragraphs, using Arial 12 pt font. Do NOT include authors’ names or affiliations in this abstract to maintain anonymity during the review process. PAWS is not responsible if affiliations are included in this abstract. Pictures, tables, and figures are allowed.
Submissions require the following information:
TITLE (short and long abstract): Should accurately reflect what was done. Please use Title Case. Arial 12 pt formatting.
AUTHORS (short abstract only): Author affiliations and contact information for the primary author. Try to make affiliations as coordinated as possible, rather than having a different affiliation for each author at the same institution. Arial 12 pt formatting. Author information is just below the title in the short abstract.
INTRODUCTION (short and long abstract): Background on general topic or previous work; include statement of purpose of the study and hypothesis. This should convey the need, significance/impact of the work.
MATERIALS & METHODS (short and long abstract): Briefly describe the methodology of research or technique used in this study. Methods should be appropriate to answer the hypothesis or problem that generated the work. Describe the subjects.
RESULTS (short and long abstract): Data should be presented in sufficient detail to support the conclusions. It is not acceptable to generalize or state, “results will be discussed”.
DISCUSSION (short and long abstract): Include an interpretation of the results. Do not simply restate the results. Was the hypothesis/problem answered? Were limitations or additional problems identified? How can the information derived from this study, or technique, best be applied to further research or clinical situation? Provide relevance and/or innovation to the current body of knowledge.
REFERENCES (long abstract): A limited number (e.g., five) of references are allowed, if necessary.
ACKNOWLEDGMENT (short and long abstract): Disclose any proprietary interest and identify financial support, either by direct funding (extramural or intramural) or materials. This MUST be provided in both the short and long abstracts for the abstracts to be considered complete. If there is no funding, you must still make a statement like “There was no proprietary interest or funding provided for this project.”
Humane Care and Use of Animals
Authors are required to certify that the study submitted was conducted in a manner consistent with the U.S. National Institutes of Health “Guide for the Care and Use of Laboratory Animals” (http://grants.nih.gov/grants/olaw/olaw.htm), the Animal Welfare Acts (US PL 89-544;91-579;94-279), and the Guide for the Care and Use of Agricultural Animals in Agricultural Research and Teaching (https://www.aaalac.org/about/Ag_Guide_3rd_ed.pdf), including appropriate methods of euthanasia (American Veterinary Medical Association Guidelines for the Euthanasia of Animals (https://www.avma.org/KB/Policies/Pages/Euthanasia-Guidelines.aspx). Regulations governing experimental animal use in some countries are more stringent than those in the US, and where this is the case, authors from those countries are cautioned to ensure that their studies meet the requirements of the country in which the study was conducted. For all other countries, the minimum standard for abstract consideration is compliance with US regulations. Inappropriate experimental use of animals or inadequate anesthesia and analgesia, including postoperative analgesia, will preclude further consideration.
If you are a person with a disability and desire any assistive devices, services or other accommodations to participate, please contact our office to discuss your needs at least 30 days prior to the event.